Astringedent X
Producto de salud natural autorizado en Canadá
- Titular
- Ultradent Products Inc.
- NPN o DIN-HM
- 80006172
- Estado
- Licencia activa
- Fecha de licencia
- 19 de junio de 2008
- Fecha de revisión
- 10 de abril de 2024
- Forma
- Solution
- Vía de administración
- Topique
- Tipo de solicitud
- Non traditionnelle
El análisis de dosis orales no se aplica sin una vía exclusivamente oral establecida.
Composición
Composición medicinal no indicada.
Ingredientes no medicinales
Eau distillée, propylèneglycol
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
Subpoblación S/O Traducido automáticamente del francés. Ver el originalSous-population S/O | No especificada Traducido automáticamente del francés. Ver el originalNon précisée | 1,2 mL | No especificada Traducido automáticamente del francés. Ver el originalNon précisée |
Subpoblación S/O Traducido automáticamente del francés. Ver el originalSous-population S/O | No especificada Traducido automáticamente del francés. Ver el originalNon précisée | No especificada Traducido automáticamente del francés. Ver el originalNon précisée | No especificada Traducido automáticamente del francés. Ver el originalNon précisée |
Usos autorizados en Canadá
Traducción no disponible. Texto original, idioma: inglés.
Hemostatic solutions - for control of bleeding, sulcular fluid control and vital pulpotomies during in-office dental procedures.Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Traducción no disponible. Texto original, idioma: inglés.
Cautions and Warnings : Prior to bonding, impressions or in the presence of any other contaminate, the tooth/preparation surface must be cleansed with a brief 2-3 seconds of 35% phosphoric acid etch followed by a firm air/water spray to remove contaminate. This is not necessary when using a conventional phosphoric acid etch bonding system. To avoid blue discoloration of soft tissues, these ferric sulfate hemostatic agents should not be mixed with epinephrine or any other epinephrine-impregnated displacement cord.
Avoid contact with clothing. Use protective clothing and protective eyewear for the dentist, assistant, and the patient when loading and handling ferric sulfate hemostatic. If contact with clothing occurs, use Astringedent Spot Remover.
Use only recommended tips.Traducción no disponible. Texto original, idioma: inglés.
Cautions and Warnings : If the hemostatic is not thoroughly washed (firm air/water spray) from the application site, the surface set of the impression can be compromised for polyether materials. Note: Use a silicon emulsion release agent when using with reversible hydrocolloid as the infusion technique of tissue management is so profound in stopping the bleeding and drying the tissues that said release agent is needed for this hydrophilic impression material. Because of the presence of iron, a temporary discoloration of the gingival tissues may appear. The patient should be reassured that this color will disappear within 24-48 hours. Care should be taken since hemostatic solutions may drip from the cord. The hemostatic solutions are yellow-colored and may temporarily stain. Being water-soluble, however, they can be washed off. They will not permanently discolor or stain enamel, dentin, or gingival. Some base materials stain on the surface but with no untoward effects. Some fabrics may stain with these hemostatics. Astringedent® Spot Remover is available for removal of stains from fabric (it should ONLY be used on fabric). Do not use on patients with known allergy to ferric sulfate or on patients with chemical hypersensitivities. Do not use self-etching primers or self-etching primer/bonding systems immediately after using Ultradent's hemostatics. If self-etching bonding agents are to be used after hemostatis, always scour surfaces with Consepsis Scrub or pumice and thoroughly wash before application. This is not necessary with conventional bonding systems that have a standalone etching step. It is also not necessary when using conventional glass ionomer, zinc phosphate, or similar cements following attainment of hemostasis. Always thoroughly and firmly wash hemostatics from tissues before applying other chemistries, for example, a rapid and potentially harmful reaction may occur with peroxides. Use protective glasses when handling/loading Ultradent materials including these hemostatics. Astringedent X is used when a stronger more potent hemostatic is required, where the attainment of quality hemostasis may be more challenging. It is not as kind to tissues as ViscoStat and Astringedent yet is kinder than other iron subsulfate solutions. Diluted Astringedent X does not equal ViscoStat or Astringedent.Traducción no disponible. Texto original, idioma: inglés.
Contra-Indications : Do not use on patients with known allergies to ferric sulfate.
For patients or users with allergy concerns, refer to product allergen document available at www.ultradent.com. If allergic reaction is observed, rinse exposed area thoroughly with water and have the patient consult their physician.Fuente
Ficha oficial de Health Canada, licencia 80006172
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPSNH)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Lista en la revisión oficial del (registro: Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias).
Lista registrada en 2024. Fotografíe el envase para comprobar si ha cambiado. Fotografiar el envase